Copyright Reports & Markets. All rights reserved.

Global Idiopathic Gastroparesis Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Idiopathic Gastroparesis Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Idiopathic Gastroparesis Drugs by Type
    • 1.3.1 Overview: Global Idiopathic Gastroparesis Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Idiopathic Gastroparesis Drugs Consumption Value Market Share by Type in 2023
    • 1.3.3 Prokinetic Agents
    • 1.3.4 Antiemetic Agents
    • 1.3.5 Others
  • 1.4 Global Idiopathic Gastroparesis Drugs Market by Application
    • 1.4.1 Overview: Global Idiopathic Gastroparesis Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Private Clinics
    • 1.4.4 Drug Stores
    • 1.4.5 E-Commerce
  • 1.5 Global Idiopathic Gastroparesis Drugs Market Size & Forecast
  • 1.6 Global Idiopathic Gastroparesis Drugs Market Size and Forecast by Region
    • 1.6.1 Global Idiopathic Gastroparesis Drugs Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Idiopathic Gastroparesis Drugs Market Size by Region, (2019-2030)
    • 1.6.3 North America Idiopathic Gastroparesis Drugs Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Idiopathic Gastroparesis Drugs Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Idiopathic Gastroparesis Drugs Market Size and Prospect (2019-2030)
    • 1.6.6 South America Idiopathic Gastroparesis Drugs Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Idiopathic Gastroparesis Drugs Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Sumitomo
    • 2.1.1 Sumitomo Details
    • 2.1.2 Sumitomo Major Business
    • 2.1.3 Sumitomo Idiopathic Gastroparesis Drugs Product and Solutions
    • 2.1.4 Sumitomo Idiopathic Gastroparesis Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Sumitomo Recent Developments and Future Plans
  • 2.2 Cadila Pharmaceuticals
    • 2.2.1 Cadila Pharmaceuticals Details
    • 2.2.2 Cadila Pharmaceuticals Major Business
    • 2.2.3 Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Product and Solutions
    • 2.2.4 Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Cadila Pharmaceuticals Recent Developments and Future Plans
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Idiopathic Gastroparesis Drugs Product and Solutions
    • 2.3.4 Sanofi Idiopathic Gastroparesis Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Sanofi Recent Developments and Future Plans
  • 2.4 Teva
    • 2.4.1 Teva Details
    • 2.4.2 Teva Major Business
    • 2.4.3 Teva Idiopathic Gastroparesis Drugs Product and Solutions
    • 2.4.4 Teva Idiopathic Gastroparesis Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Teva Recent Developments and Future Plans
  • 2.5 Johnson & Johnson
    • 2.5.1 Johnson & Johnson Details
    • 2.5.2 Johnson & Johnson Major Business
    • 2.5.3 Johnson & Johnson Idiopathic Gastroparesis Drugs Product and Solutions
    • 2.5.4 Johnson & Johnson Idiopathic Gastroparesis Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Idiopathic Gastroparesis Drugs Product and Solutions
    • 2.6.4 Pfizer Idiopathic Gastroparesis Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Pfizer Recent Developments and Future Plans
  • 2.7 Kyowa Kirin Pharmaceuticals
    • 2.7.1 Kyowa Kirin Pharmaceuticals Details
    • 2.7.2 Kyowa Kirin Pharmaceuticals Major Business
    • 2.7.3 Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Product and Solutions
    • 2.7.4 Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Kyowa Kirin Pharmaceuticals Recent Developments and Future Plans
  • 2.8 Hanmi Pharm
    • 2.8.1 Hanmi Pharm Details
    • 2.8.2 Hanmi Pharm Major Business
    • 2.8.3 Hanmi Pharm Idiopathic Gastroparesis Drugs Product and Solutions
    • 2.8.4 Hanmi Pharm Idiopathic Gastroparesis Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Hanmi Pharm Recent Developments and Future Plans
  • 2.9 Ani Pharmaceuticals
    • 2.9.1 Ani Pharmaceuticals Details
    • 2.9.2 Ani Pharmaceuticals Major Business
    • 2.9.3 Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Product and Solutions
    • 2.9.4 Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Ani Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Idiopathic Gastroparesis Drugs Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Idiopathic Gastroparesis Drugs by Company Revenue
    • 3.2.2 Top 3 Idiopathic Gastroparesis Drugs Players Market Share in 2023
    • 3.2.3 Top 6 Idiopathic Gastroparesis Drugs Players Market Share in 2023
  • 3.3 Idiopathic Gastroparesis Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 Idiopathic Gastroparesis Drugs Market: Region Footprint
    • 3.3.2 Idiopathic Gastroparesis Drugs Market: Company Product Type Footprint
    • 3.3.3 Idiopathic Gastroparesis Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Idiopathic Gastroparesis Drugs Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Idiopathic Gastroparesis Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Idiopathic Gastroparesis Drugs Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Idiopathic Gastroparesis Drugs Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Idiopathic Gastroparesis Drugs Consumption Value by Type (2019-2030)
  • 6.2 North America Idiopathic Gastroparesis Drugs Consumption Value by Application (2019-2030)
  • 6.3 North America Idiopathic Gastroparesis Drugs Market Size by Country
    • 6.3.1 North America Idiopathic Gastroparesis Drugs Consumption Value by Country (2019-2030)
    • 6.3.2 United States Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Idiopathic Gastroparesis Drugs Consumption Value by Type (2019-2030)
  • 7.2 Europe Idiopathic Gastroparesis Drugs Consumption Value by Application (2019-2030)
  • 7.3 Europe Idiopathic Gastroparesis Drugs Market Size by Country
    • 7.3.1 Europe Idiopathic Gastroparesis Drugs Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 7.3.3 France Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Idiopathic Gastroparesis Drugs Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Idiopathic Gastroparesis Drugs Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Idiopathic Gastroparesis Drugs Market Size by Region
    • 8.3.1 Asia-Pacific Idiopathic Gastroparesis Drugs Consumption Value by Region (2019-2030)
    • 8.3.2 China Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 8.3.5 India Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Idiopathic Gastroparesis Drugs Consumption Value by Type (2019-2030)
  • 9.2 South America Idiopathic Gastroparesis Drugs Consumption Value by Application (2019-2030)
  • 9.3 South America Idiopathic Gastroparesis Drugs Market Size by Country
    • 9.3.1 South America Idiopathic Gastroparesis Drugs Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Idiopathic Gastroparesis Drugs Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Idiopathic Gastroparesis Drugs Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Idiopathic Gastroparesis Drugs Market Size by Country
    • 10.3.1 Middle East & Africa Idiopathic Gastroparesis Drugs Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Idiopathic Gastroparesis Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Idiopathic Gastroparesis Drugs Market Drivers
  • 11.2 Idiopathic Gastroparesis Drugs Market Restraints
  • 11.3 Idiopathic Gastroparesis Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Idiopathic Gastroparesis Drugs Industry Chain
  • 12.2 Idiopathic Gastroparesis Drugs Upstream Analysis
  • 12.3 Idiopathic Gastroparesis Drugs Midstream Analysis
  • 12.4 Idiopathic Gastroparesis Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Idiopathic Gastroparesis Drugs market size was valued at USD 3668.2 million in 2023 and is forecast to a readjusted size of USD 5219.6 million by 2030 with a CAGR of 5.2% during review period.
    Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Idiopathic Gastroparesis Drugs industry chain, the market status of Hospital Pharmacies (Prokinetic Agents, Antiemetic Agents), Private Clinics (Prokinetic Agents, Antiemetic Agents), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Idiopathic Gastroparesis Drugs.
    Regionally, the report analyzes the Idiopathic Gastroparesis Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Idiopathic Gastroparesis Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Idiopathic Gastroparesis Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Idiopathic Gastroparesis Drugs industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Prokinetic Agents, Antiemetic Agents).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Idiopathic Gastroparesis Drugs market.
    Regional Analysis: The report involves examining the Idiopathic Gastroparesis Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Idiopathic Gastroparesis Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Idiopathic Gastroparesis Drugs:
    Company Analysis: Report covers individual Idiopathic Gastroparesis Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Idiopathic Gastroparesis Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Private Clinics).
    Technology Analysis: Report covers specific technologies relevant to Idiopathic Gastroparesis Drugs. It assesses the current state, advancements, and potential future developments in Idiopathic Gastroparesis Drugs areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Idiopathic Gastroparesis Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Idiopathic Gastroparesis Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Prokinetic Agents
    Antiemetic Agents
    Others
    Market segment by Application
    Hospital Pharmacies
    Private Clinics
    Drug Stores
    E-Commerce
    Market segment by players, this report covers
    Sumitomo
    Cadila Pharmaceuticals
    Sanofi
    Teva
    Johnson & Johnson
    Pfizer
    Kyowa Kirin Pharmaceuticals
    Hanmi Pharm
    Ani Pharmaceuticals
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Idiopathic Gastroparesis Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Idiopathic Gastroparesis Drugs, with revenue, gross margin and global market share of Idiopathic Gastroparesis Drugs from 2019 to 2024.
    Chapter 3, the Idiopathic Gastroparesis Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Idiopathic Gastroparesis Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Idiopathic Gastroparesis Drugs.
    Chapter 13, to describe Idiopathic Gastroparesis Drugs research findings and conclusion.

    Buy now